Bioheaven 360 Genotec Profile
Key Indicators
- Authorised Capital ₹ 1.10 M
as on 04-07-2024
- Paid Up Capital ₹ 0.11 M
as on 04-07-2024
- Company Age 6 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 0.72 M
as on 04-07-2024
- Revenue 157.27%
(FY 2023)
- Profit -14.68%
(FY 2023)
- Ebitda 105.48%
(FY 2023)
- Net Worth 415.71%
(FY 2023)
- Total Assets 361.90%
(FY 2023)
About Bioheaven 360 Genotec
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.10 M and a paid-up capital of Rs 0.11 M.
The company currently has active open charges totaling ₹0.72 M.
Suman Kumari, Shailendra Vyas, and Sanjay Nagi serve as directors at the Company.
- CIN/LLPIN
U93010DL2018PTC331663
- Company No.
331663
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Mar 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Bioheaven 360 Genotec Private Limited offer?
Bioheaven 360 Genotec Private Limited offers a wide range of products and services, including Medical Laboratory Instruments, Corona Test Kit.
Who are the key members and board of directors at Bioheaven 360 Genotec?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shailendra Vyas  | Director | 27-Mar-2018 | Current |
| Suman Kumari | Director | 27-Mar-2018 | Current |
| Sanjay Nagi | Director | 24-Jul-2020 | Current |
Financial Performance of Bioheaven 360 Genotec.
Bioheaven 360 Genotec Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 157.27% increase. The company also saw a substantial fall in profitability, with a 14.68% decrease in profit. The company's net worth Soared by an impressive increase of 415.71%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bioheaven 360 Genotec?
In 2023, Bioheaven 360 Genotec had a promoter holding of 93.38% and a public holding of 6.62%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Tomorrow's Market Innovators Private LimitedActive 11 years 10 monthsSanjay Nagi is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 09 Mar 2019 | ₹0.72 M | Open |
How Many Employees Work at Bioheaven 360 Genotec?
Unlock and access historical data on people associated with Bioheaven 360 Genotec, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bioheaven 360 Genotec, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bioheaven 360 Genotec's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
